miRNAsong: a web-based tool for generation and testing of miRNA sponge constructs in silico

MicroRNA (miRNA) sponges are RNA transcripts containing multiple high-affinity binding sites that associate with and sequester specific miRNAs to prevent them from interacting with their target messenger (m)RNAs. Due to the high specificity of miRNA sponges and strong inhibition of target miRNAs, these molecules have become increasingly applied in miRNA loss-of-function studies. However, improperly designed sponge constructs may sequester off-target miRNAs; thus, it has become increasingly important to develop a tool for miRNA sponge construct design and testing. In this study, we introduce microRNA sponge generator and tester (miRNAsong), a freely available web-based tool for generation and in silico testing of miRNA sponges. This tool generates miRNA sponge constructs for specific miRNAs and miRNA families/clusters and tests them for potential binding to miRNAs in selected organisms. Currently, miRNAsong allows for testing of sponge constructs in 219 species covering 35,828 miRNA sequences. Furthermore, we also provide an example, supplemented with experimental data, of how to use this tool. Using miRNAsong, we designed and tested a sponge for miR-145 inhibition, and cloned the sequence into an inducible lentiviral vector. We found that established cell lines expressing miR-145 sponge strongly inhibited miR-145, thus demonstrating the usability of miRNAsong tool for sponge generation. URL: http://www.med.muni.cz/histology/miRNAsong/.

[1]  Peter T Nelson,et al.  Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways. , 2007, Molecular genetics and metabolism.

[2]  Juyoung Ham,et al.  MicroRNA Target Recognition: Insights from Transcriptome-Wide Non-Canonical Interactions , 2016, Molecules and cells.

[3]  S. Muljo,et al.  Prospects for Therapeutic Targeting of MicroRNAs in Human Immunological Diseases , 2015, The Journal of Immunology.

[4]  H. Iba,et al.  Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells , 2009, Nucleic acids research.

[5]  G. Pan,et al.  MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells , 2009, Cell.

[6]  P. Ismail,et al.  MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment. , 2015, Pharmacological research.

[7]  R. Giegerich,et al.  Fast and effective prediction of microRNA/target duplexes. , 2004, RNA.

[8]  R. Lo,et al.  The cumate gene-switch: a system for regulated expression in mammalian cells , 2006 .

[9]  A. Ganser,et al.  Lentivirus-mediated antagomir expression for specific inhibition of miRNA function , 2007, Nucleic acids research.

[10]  Sam Griffiths-Jones,et al.  The microRNA Registry , 2004, Nucleic Acids Res..

[11]  A. Garnier,et al.  High‐level recombinant protein production in CHO cells using lentiviral vectors and the cumate gene‐switch , 2010, Biotechnology and bioengineering.

[12]  N. Wu,et al.  MicroRNA-145 Function as a Cell Growth Repressor by Directly Targeting c-Myc in Human Ovarian Cancer , 2014, Technology in cancer research & treatment.

[13]  Ana Kozomara,et al.  miRBase: integrating microRNA annotation and deep-sequencing data , 2010, Nucleic Acids Res..

[14]  L. Kiesel,et al.  MicroRNA miR-145 inhibits proliferation, invasiveness, and stem cell phenotype of an in vitro endometriosis model by targeting multiple cytoskeletal elements and pluripotency factors. , 2013, Fertility and sterility.

[15]  Yi Jing,et al.  Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs , 2015, Proceedings of the National Academy of Sciences.

[16]  Phillip A Sharp,et al.  MicroRNA sponges: progress and possibilities. , 2010, RNA.

[17]  George Coukos,et al.  Therapeutic MicroRNA Strategies in Human Cancer , 2009, The AAPS Journal.

[18]  R. Bak,et al.  Potent microRNA suppression by RNA Pol II-transcribed 'Tough Decoy' inhibitors. , 2013, RNA.

[19]  M. Mraz,et al.  MicroRNAs in B-cell lymphomas: how a complex biology gets more complex , 2014, Leukemia.

[20]  R. Bak,et al.  Suppression of microRNAs by dual-targeting and clustered Tough Decoy inhibitors , 2013, RNA biology.

[21]  J. SantaLucia,et al.  A unified view of polymer, dumbbell, and oligonucleotide DNA nearest-neighbor thermodynamics. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[22]  William A. Rennie,et al.  CLIP-based prediction of mammalian microRNA binding sites , 2013, Nucleic acids research.

[23]  Peng Wang,et al.  miRSponge: a manually curated database for experimentally supported miRNA sponges and ceRNAs , 2015, Database J. Biol. Databases Curation.

[24]  Y. Shao,et al.  MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6 , 2013, Cancer Cell International.

[25]  Hailong Wu,et al.  p53 represses c-Myc through induction of the tumor suppressor miR-145 , 2009, Proceedings of the National Academy of Sciences.

[26]  Li Liu,et al.  Synthetic miRNA sponges driven by mutant hTERT promoter selectively inhibit the progression of bladder cancer , 2015, Tumor Biology.

[27]  G. Calin,et al.  MicroRNAs in cancer therapeutics: “from the bench to the bedside” , 2015, Expert opinion on biological therapy.

[28]  C. Rodrigues,et al.  MicroRNA‐145 Regulates Neural Stem Cell Differentiation Through the Sox2–Lin28/let‐7 Signaling Pathway , 2016, Stem cells.

[29]  Ales Hampl,et al.  MicroRNAs Regulate p21Waf1/Cip1 Protein Expression and the DNA Damage Response in Human Embryonic Stem Cells , 2012, Stem cells.

[30]  V. Athyros,et al.  Is Targeting microRNAs the Philosopher's Stone for Vascular Disease? , 2015, Current vascular pharmacology.

[31]  Margaret S. Ebert,et al.  MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells , 2007, Nature Methods.

[32]  C. Esau,et al.  Inhibition of microRNA with antisense oligonucleotides. , 2008, Methods.

[33]  Wenfang S. Wu,et al.  A PCR-after-ligation method for cloning of multiple DNA inserts. , 2010, Analytical biochemistry.

[34]  Ivo L. Hofacker,et al.  Vienna RNA secondary structure server , 2003, Nucleic Acids Res..

[35]  Wei Guo,et al.  miR-143 and miR-145 inhibit stem cell characteristics of PC-3 prostate cancer cells. , 2012, Oncology reports.

[36]  Tao Sun,et al.  An Optimized Sponge for microRNA miR-9 Affects Spinal Motor Neuron Development in vivo , 2011, Front. Neurosci..

[37]  D. Bartel MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[38]  Jan Krüger,et al.  RNAhybrid: microRNA target prediction easy, fast and flexible , 2006, Nucleic Acids Res..

[39]  A. Schier,et al.  Target Protectors Reveal Dampening and Balancing of Nodal Agonist and Antagonist by miR-430 , 2007, Science.

[40]  Michael Kertesz,et al.  The role of site accessibility in microRNA target recognition , 2007, Nature Genetics.

[41]  Š. Pospíšilová,et al.  EMBRYONIC STEM CELLS/INDUCED PLURIPOTENT STEM CELLS MicroRNAs Regulate p21 Waf1/Cip1 Protein Expression and the DNA Damage Response in Human Embryonic Stem Cells , 2012 .

[42]  D. Montaner,et al.  Brief Report: Inhibition of miR‐145 Enhances Reprogramming of Human Dermal Fibroblasts to Induced Pluripotent Stem Cells , 2015, Stem cells.

[43]  Grace X. Y. Zheng,et al.  MicroRNAs can generate thresholds in target gene expression , 2011, Nature Genetics.

[44]  Stijn van Dongen,et al.  miRBase: microRNA sequences, targets and gene nomenclature , 2005, Nucleic Acids Res..

[45]  Ye Ding,et al.  Rapid Generation of MicroRNA Sponges for MicroRNA Inhibition , 2012, PloS one.

[46]  A. van den Berg,et al.  Generation of miRNA sponge constructs. , 2012, Methods.

[47]  R. Jain,et al.  RNA interference-based therapeutics: molecular platforms for infectious diseases. , 2014, Journal of biomedical nanotechnology.

[48]  K. Lee,et al.  MicroRNA-221 sponge therapy attenuates neointimal hyperplasia and improves blood flows in vein grafts. , 2016, International journal of cardiology.

[49]  S. Kauppinen,et al.  Treatment of HCV infection by targeting microRNA. , 2013, The New England journal of medicine.

[50]  Luigi Naldini,et al.  Stable knockdown of microRNA in vivo by lentiviral vectors , 2009, Nature Methods.

[51]  Stijn van Dongen,et al.  miRBase: tools for microRNA genomics , 2007, Nucleic Acids Res..